Why this call
A Healthcare Giant at a Premium Price
Continued positive momentum and news flow.
High P/E ratio may act as a cap on significant gains.
Steady business performance provides support.
Weather forecast
Partly cloudy
Hold
Score 60/100 · Confidence 60%
A mixed forecast — patience tends to pay here.
Why this call
Continued positive momentum and news flow.
High P/E ratio may act as a cap on significant gains.
Steady business performance provides support.
Where it's headed
As of Nov 13, 2026, Tickerday rates Johnson & Johnson (JNJ) a Hold, score 60/100, with 60% confidence. Each target is measured from $283.52, the price that day.
Next week
$284.50
+0.3% from $283.52
Strong momentum may push the stock slightly higher, but its position at a 52-week high could invite some profit-taking.
Next month
$287
+1.2% from $283.52
The stock's positive trend could face resistance as investors weigh its high valuation against solid fundamentals.
Next year
$303.50
+7.0% from $283.52
The company's fundamental strengths are likely already reflected in the high share price, suggesting returns may align with earnings growth.
Under the hood
Six factors, scored 0–100 from live market and financial data — the same read Wall Street does, minus the jargon.
The stock appears expensive based on its current earnings.
The company is posting solid and steady revenue growth.
J&J has strong margins, turning a good portion of sales into profit.
The stock has been in a strong uptrend and is trading near its yearly high.
The company has a very strong balance sheet with low levels of debt.
Recent news and market mood appear positive.
Size and price
Growth and profit
Risk and payout
The argument
Every call has a case against it. Here's the honest version of both.
The bull case
The bear case
FAQ
Tickerday's read of Johnson & Johnson as of Nov 13, 2026: educational analysis, the same for everyone, not financial advice.
Most tools hand you the data.
Tickerday hands you the answer.
Now try yours
You just read Johnson & Johnson. Type a company you own and get its call, and the why, in seconds. First one free, no account needed.
The receipts
Real calls from the Tickerday engine, each one graded against the real price a month later.
Every call is graded
One month after the call, at the closing price.

+52.3%
✓Called it
We said Buy at $122.33 on Jul 30. A month later the price was $186.29.
Graded Aug 28 at the closing price
Weather alerts
Save a stock to your Almanac. We'll track its forecast and let you know when the outlook changes.
Your Almanac
Watching 4 stocks
JNJ
Johnson & Johnson
Hold
AAPL
Apple
Buy
MSFT
Microsoft
Buy
TSLA
Tesla
Sell
Thursday, October 16
9:41
Nothing to chase. Nothing to refresh.

One blind call costs more
than a year of Tickerday.
Pricing
Your first analysis is free, no account needed. Tickerday+ takes it from there.
Tickerday+
Pro
Built for fast clarity.
Billed monthly · ≈ $0.30/day
Tickerday+
Most popularPremium
The full why, explained.
Billed yearly · ≈ $14.08/mo≈ $0.46/day
Cancel anytime.

Get the full picture
You just understood JNJ without reading a single chart. The Tickerday app does this for your whole watchlist — today's read whenever you want it, the full thesis, bull and bear scenarios with their odds — and wakes you the moment the weather turns.
One plain answer for every stock — Buy, Hold, or Sell
The full picture in seconds — thesis, targets & scenarios
Sleep easy — we watch the market and wake you if it turns
Free to download the day it lands — the web desk is open now
More forecasts
Head to head
More lists